CPT Capital

CPT Capital CPT Capital is the venture arm of a leading private family office and one of the pioneer investors in alternative protein. with arguably unmatched sector expertise. The portfolio of 58 investments includes 4 unicorns (Beyond Meat and Impossible Foods among them), 2 IPOs, and 4 acquisitions. They led ENOUGH's $43.5M Series B (mycoprotein technology) alongside HAL and Scottish Enterprise, demonstrating willingness to write significant checks into frontier food technology. The family o